 Patient Advocate (1000+ posts)
Joined: Jan 2013 Posts: 1,293 Likes: 1 | Thanks Matthew. Than confirms what I read of the goals of 1016 - that is to not determine of cetuximab was more effective as a cancer agent, rather if the side effects might be less using that drug. Did you happen to research completed trials where those two drugs were specifically compared? Seems like that match up would exist. Thanks Don
Don Male, 57 - Great health except C Dec '12 DX: BOT SCC T2N2bMx, Stage 4a, HPV+, multiple nodes 1 tooth out Jan '13 2nd tooth out Tumor Board -induction TPF (3 cycles), seq CRT 4-6/2013 CRT 70gr 2x35, weekly carbo150 ended 5/29,6/4 All the details, join at http://beatdown.cognacom.com | 
